This federal contract award, valued at $2,994.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Menveo A-C-Y-W kits, which are vaccines used for the prevention of meningococcal disease. The contract has an ultimate completion date of December 16, 2024 and is a firm fixed-price delivery order. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization and a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company maintains several Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000 respectively, for the provision of a comprehensive range of pharmaceutical products and medical supplies to support federal medical institutions and healthcare programs.
Generated 3/14/25, 10:04 AM